Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Limoran Tang

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Prevention of Alzheimer'S Disease|March 14, 2026
Donanemab therapy in Alzheimer's disease with mild cognitive impairment: Convergent amyloid, tau, and plasma biomarker normalization with cognitive improvementLimoran Tang, Yun Xu, Hui Zhao
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentHui Zhao, Limoran Tang, Dan Yang, et al.
CNS Neuroscience & Therapeutics|May 8, 2024
Inhibition of ADORA3 promotes microglial phagocytosis and alleviates chronic ischemic white matter injuryYuhao Xu, Limoran Tang, Chao Zhou, et al.
Current Neuropharmacology|June 2, 2026
Neuro-navigated rTMS Targeting Left Angular Gyrus Promotes White-Gray Matter Remodelling to Improve Cognitive Function in Amnestic Mild Cognitive Impairment Patients: Evidence for Early Alzheimer.s InterventionZhiyuan Yang, Xinle Hou, Yi Tan, et al.
Human Brain Mapping|July 11, 2025
The Effect of APOE ε4 Allele on Dynamic Local Spontaneous Brain Activity and Functional Integration in Alzheimer's DiseaseYi Tan, Dan Yang, Zhihong Ke, et al.
CNS Neuroscience & Therapeutics|July 13, 2024
Connectome gradient dysfunction contributes to white matter hyperintensity-related cognitive declineDan Yang, Yi Tan, ZhiXin Zhou, et al.
ACS Sensors|November 24, 2025
A Surface-Engineered Microfluidic Platform with Algorithmic Optimization for Plasma Biomarker Detection in Alzheimer's DiseaseYue Cheng, Limoran Tang, Yi Tan, et al.
Alzheimer'S Research & Therapy|April 30, 2026
Performance of plasma pTau217, pTau181 and their ratios to Aβ42 in detecting Aβ pathology using a China-developed direct chemiluminescence assayDan Yang, Zhihong Ke, Nihong Chen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Prevention of Alzheimer'S Disease|March 14, 2026
Donanemab therapy in Alzheimer's disease with mild cognitive impairment: Convergent amyloid, tau, and plasma biomarker normalization with cognitive improvementLimoran Tang, Yun Xu, Hui Zhao
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentHui Zhao, Limoran Tang, Dan Yang, et al.
CNS Neuroscience & Therapeutics|May 8, 2024
Inhibition of ADORA3 promotes microglial phagocytosis and alleviates chronic ischemic white matter injuryYuhao Xu, Limoran Tang, Chao Zhou, et al.
Current Neuropharmacology|June 2, 2026
Neuro-navigated rTMS Targeting Left Angular Gyrus Promotes White-Gray Matter Remodelling to Improve Cognitive Function in Amnestic Mild Cognitive Impairment Patients: Evidence for Early Alzheimer.s InterventionZhiyuan Yang, Xinle Hou, Yi Tan, et al.
Human Brain Mapping|July 11, 2025
The Effect of APOE ε4 Allele on Dynamic Local Spontaneous Brain Activity and Functional Integration in Alzheimer's DiseaseYi Tan, Dan Yang, Zhihong Ke, et al.
CNS Neuroscience & Therapeutics|July 13, 2024
Connectome gradient dysfunction contributes to white matter hyperintensity-related cognitive declineDan Yang, Yi Tan, ZhiXin Zhou, et al.
ACS Sensors|November 24, 2025
A Surface-Engineered Microfluidic Platform with Algorithmic Optimization for Plasma Biomarker Detection in Alzheimer's DiseaseYue Cheng, Limoran Tang, Yi Tan, et al.
Alzheimer'S Research & Therapy|April 30, 2026
Performance of plasma pTau217, pTau181 and their ratios to Aβ42 in detecting Aβ pathology using a China-developed direct chemiluminescence assayDan Yang, Zhihong Ke, Nihong Chen, et al.
Pageof 1